Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension

被引:114
作者
Patterson, Karen C. [1 ]
Weissmann, Ariel [1 ]
Ahmadi, Tahamtan [1 ]
Farber, Harrison W. [1 ]
机构
[1] Boston Univ, Med Ctr, Boston, MA 02118 USA
关键词
D O I
10.7326/0003-4819-145-2-200607180-00020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:152 / 153
页数:2
相关论文
共 5 条
[1]   Sildenafil citrate therapy for pulmonary arterial hypertension [J].
Galiè, N ;
Ghofrani, HA ;
Torbicki, A ;
Barst, RJ ;
Rubin, LJ ;
Badesch, D ;
Fleming, T ;
Parpia, T ;
Burgess, G ;
Branzi, A ;
Grimminger, F ;
Kurzyna, M ;
Simonneau, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2148-2157
[2]   Imatinib for the treatment of pulmonary arterial hypertension [J].
Ghofrani, HA ;
Seeger, W ;
Grimminger, F .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) :1412-1413
[3]  
Humbert M, 1998, EUR RESPIR J, V11, P554
[4]   Reversal of experimental pulmonary hypertension by PDGF inhibition [J].
Schermuly, RT ;
Dony, E ;
Ghofrani, HA ;
Pullamsetti, S ;
Savai, R ;
Roth, M ;
Sydykov, A ;
Lai, YJ ;
Weissmann, N ;
Seeger, W ;
Grimminger, F .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (10) :2811-2821
[5]   Safety and efficacy of IV treprostinil for pulmonary arterial hypertension - A prospective, multicenter, open-label, 12-week trial [J].
Tapson, VF ;
Gomberg-Maitland, M ;
McLaughlin, VV ;
Benza, RL ;
Widlitz, AC ;
Krichman, A ;
Barst, RJ .
CHEST, 2006, 129 (03) :683-688